The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,937,071 in first-year total cost, median $1,152,658.
Most frequent study sections
- Special Emphasis Panel[ZMH1 ERB-C (03)]3
Most frequent institutions
- BOSTON CHILDREN'S HOSPITAL1
- BROAD INSTITUTE, INC.1
- GEISINGER CLINIC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders1U01MH119705-01 | LEDBETTER, DAVID H.MARTIN, CHRISTA LESE | GEISINGER CLINIC, PA | $1,738,336 | ZMH1 |
| 2019 | Rare genetic disorders in NeuroDev: Insight into the genetic and phenotypic heterogeneity of ID, ASD and ADHD in South African Populations1U01MH119689-01 | DONALD, KIRSTYO'DONNELL-LURIA, ANNEROBINSON, ELISE B | BROAD INSTITUTE, INC., MA | $1,152,658 | ZMH1 |
| 2019 | Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive Ability1U01MH119690-01 | ALMASY, LAURA A.GLAHN, DAVID CJACQUEMONT, SEBASTIEN | BOSTON CHILDREN'S HOSPITAL, MA | $1,046,077 | ZMH1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.